| Methods |
RCT comparing rosiglitazone versus metformin plus sulphonylurea in patients with type 2 diabetes. |
| Data |
4447 patients were randomised (2220/2227, respectively in each treatment group). |
| Comparisons |
Onsite assessment (local investigator non blinded) versus assessment by an AC blinded to allocated treatment. |
| Outcomes |
The outcome selected was myocardial infarction. The study's primary outcome was cardiovascular hospitalisation or cardiovascular death.. |
| Notes |
The study was identified because it was included in a review (Serebruany 2012). Data related to the number of events in each treatment group resulting from onsite‐assessor and AC assessments were extracted from this review. |
| Risk of bias |
| Item |
Authors' judgement |
Description |
| Method for selecting cases to adjudicate? |
Yes |
All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment. |
